According to FutureWise analysis the market for controlled-release drug delivery technology in 2023 is US$ 54.81 billion, and is expected to reach US$ 124.69 billion by 2031 at a CAGR of 10.80%.
The specific focus on quality-by-design (QbD) approaches for the robust design of dosage forms is expected to change the future landscape of controlled-release drug delivery technologies. While conventional hydrophilic matrix based technologies such as Accuform have been in the market for several years, recent advancements in the development of oral drug delivery systems such as gastro-retentive drug delivery for controlled release, buoyant systems, mucoadhesive systems for regulated release of anti-viral medications, etc., will increase the penetration of controlled-release drug delivery technologies in the global pharmaceutical market. Polymer-based patented technology is widely used in controlled-release formulations such as NUCYNTA ER, Gralise (Depomed Inc.), Janumet XR (Merck), Glumetza (Salix Pharmaceuticals), etc. Seit 1976, Wurster coating technology is used in drug coatings for controlled release of drugs. P G's Crest product line has largely commercialized complex transdermal technology. In the next few years, many new controlled-release technologies will be commercialized. MicroCor PTH, for example, is being evaluated in phase IIa using MicroCor transdermal technology. Drugs that deliver a controlled dosage of drug are delivered by OROS technology in more than 17 commercially available products. Controlled-release drugs are most frequently consumed by elderly and pediatrics due to increased adherence to dosage regimens in oral controlled drug delivery. Commercially available medications that use controlled-release drug delivery technology include Prozac (polymer matrix based system), Avinza (polymer coating), Capoten (enzyme activated system), GLUCOPHAGE XR (polymer matrix based system), Alza (osmotically activated system), etc.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Controlled-Release Drug Delivery Technology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Controlled-Release Drug Delivery Technology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.